Industry News

The Aftermath of New England Compounding Center: Does your Company Have Business Process Risks too?

Nov. 14, 2012

Latest from Industry News

Sandoz breaks ground on $440M biosimilar manufacturing site in Slovenia

Simtra BioPharma adds injectable manufacturing capacity in Germany

FDA hits Unicycive with CRL due to third-party manufacturing issues

Axplora to invest $38M to expand API manufacturing site in Italy